5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 322.35▲ | 311.45▲ |
MA10 | N/A | N/A | N/A | 323.20▼ | 302.23▲ |
MA20 | N/A | N/A | N/A | 312.58▲ | 282.80▲ |
MA50 | N/A | N/A | N/A | 300.40▲ | 283.06▲ |
MA100 | N/A | N/A | N/A | 284.84▲ | 240.56▲ |
MA200 | N/A | N/A | N/A | 289.59▲ | 202.11▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.067▼ | 5.174▲ |
RSI | N/A | N/A | N/A | 64.413▲ | 62.569▲ |
STOCH | N/A | N/A | N/A | 65.701 | 93.099▲ |
WILL %R | N/A | N/A | N/A | -21.688▲ | -5.417▲ |
CCI | N/A | N/A | N/A | 51.752 | 121.581▲ |
Friday, May 02, 2025 04:14 AM
KUCHING: Sarawak is exploring a strategic partnership with the London School of Economics and Political Science (LSE) in education and research.
|
Wednesday, April 30, 2025 06:36 AM
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14 ...
|
Wednesday, April 09, 2025 07:48 AM
AstraZeneca (LSE:AZN) saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 323.00 | 323.71 | 323.00 | 323.00 | 23 |
10/07/25 | 321.00 | 321.33 | 321.00 | 321.00 | 69 |
09/07/25 | 319.25 | 320.38 | 319.25 | 319.25 | 160 |
08/07/25 | 324.00 | 326.8024 | 324.00 | 324.00 | 9 |
07/07/25 | 324.50 | 326.8024 | 324.50 | 324.50 | 2,597 |
04/07/25 | 328.50 | 328.50 | 321.74 | 328.50 | 47 |
03/07/25 | 324.50 | 328.00 | 321.74 | 328.00 | 47 |
02/07/25 | 321.74 | 325.00 | 321.74 | 325.00 | 65 |
01/07/25 | 318.75 | 318.75 | 314.96 | 318.75 | 1,462 |
30/06/25 | 320.00 | 320.00 | 314.96 | 320.00 | 100 |
|
|
||||
|
|
||||
|
|